Mcl-1 is also critical for the survival of human MM cells in vitro, as higher levels of Mcl-1 in malignant plasma cells from patients with MM have been correlated with relapse and shorter OS [44] Furthermore, the upregulation of Mcl-1 has been implicated in venetoclax resistance in MM [45]. This evidence concerns the gene MCL1 and Miyoshi myopathy.